References
- Harish A, Schwartz SA. Targeted anti-IL-5 therapies and future therapeutics for hypereosinophilic syndrome and rare eosinophilic conditions. Clin Rev Allergy Immunol. 2020;59(2):231–247. doi:10.1007/s12016-019-08775-4
- Chen Z, Bozec A, Ramming A, Schett G. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol. 2019;15(1):9–17. doi:10.1038/s41584-018-0109-2
- Suzuki Y, Suda T. Eosinophilic pneumonia: a review of the previous literature, causes, diagnosis, and management. Allergol Int. 2019;68(4):413–419. doi:10.1016/j.alit.2019.05.006
- Chen Z, Andreev D, Oeser K, et al. Th2 and eosinophil responses suppress inflammatory arthritis. Nat Commun. 2016;7(1):11596. doi:10.1038/ncomms11596
- Andreev D, Liu M, Kachler K, et al. Regulatory eosinophils induce the resolution of experimental arthritis and appear in remission state of human rheumatoid arthritis. Ann Rheum Dis. 2020;80(4):451–468. doi:10.1136/annrheumdis-2020-218902
- Khatri S, Moore W, Gibson PG, et al. Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma. J Allergy Clin Immunol. 2019;143(5):1742–1751. doi:10.1016/j.jaci.2018.09.033
- Liu W, Ma X, Zhou W. Adverse events of benralizumab in moderate to severe eosinophilic asthma: a meta-analysis. Medicine. 2019;98(22):e15868. doi:10.1097/MD.0000000000015868
- Roufosse FE, Kahn JE, Gleich GJ, et al. Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes. J Allergy Clin Immunol. 2013;131(2):461–467. doi:10.1016/j.jaci.2012.07.055
- Yamada H, Hida N, Kurashima Y, et al. A case of severe eosinophilic asthma and refractory rheumatoid arthritis well controlled by combination of IL-5Ralpha antibody and TNFalpha inhibitor. Allergol Int. 2019;68(4):536–538. doi:10.1016/j.alit.2019.04.003
- Tsukamoto N, Takahashi N, Itoh H, et al. Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-Interleukin 5 monoclonal antibody, in healthy Japanese male subjects. Clin Pharmacol Drug Dev. 2018;5(2):102–108. doi:10.1002/cpdd.205
- Quirke AM, Perry E, Cartwright A, et al. Bronchiectasis is a model for chronic bacterial infection inducing autoimmunity in rheumatoid arthritis. Arthritis Rheumatol. 2015;67(9):2335–2342. doi:10.1002/art.39226
- Groh M, Pagnoux C, Baldini C, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med. 2015;26(7):545–553. doi:10.1016/j.ejim.2015.04.022